Guardian Consulting Services, Inc.
Classification
Private
About
About
Guardian Consulting Services, Inc. is a healthcare services company that has been operating since 1989, with its headquarters located in New Hyde Park, New York. The company provides specialized clinical and administrative consulting services primarily to long-term care facilities, including skilled nursing facilities and assisted living communities. Guardian Consulting Services, Inc. focuses on medication management and regulatory compliance through its team of consultant pharmacists and nursing professionals. Business/Product Breakdown Guardian Consulting Services, Inc. offers clinical pharmacy consulting and specialized healthcare advisory services designed to enhance patient safety and operational efficiency in post-acute care settings. The company's core offerings include comprehensive medication regimen reviews, which involve evaluating drug therapies to identify potential adverse reactions or irregularities. Additionally, the firm provides administrative support services such as mock surveys and audits to assist facilities in maintaining compliance with state and federal healthcare regulations. These services extend to clinical educational programs for facility staff, covering topics such as infection control, wound care, and specialized dementia care. Through its technical expertise, the company also assists healthcare providers with the implementation of electronic health record systems and medication cart audits.
Financials
Revenue & Profit
Valuation
Ratios
People
Employee Figures
Key Executives
| Name | Title | Socials | Phone | |
|---|---|---|---|---|
| John Doe | Employee | -- | ||
| Jane Doe | Employee | |||
| John Doe | Employee | |||
| John Doe | Employee |
401K
Deals
M&A2024-03-15Completed
Investor Sponsors NorthBridge PE | Stake Tags 100% |
Deal Amount $120M | Is PE deal Yes |
Target Company Valuation $1.20 MM | Is deal PE backed Yes |
Techniques Acquisition of Assets, Taken Private | Total Acquired 100% |
Investor Sponsors
Deal Amount
$120M
Target Company Valuation
$1.20 MM
Techniques
Acquisition of Assets, Taken Private
Stake Tags
100%
Is PE deal
Yes
Is deal PE backed
Yes
Total Acquired
100%
Secondary Transaction2023-09-01Canceled
Investor Sponsors -- | Stake Tags Majority |
Deal Amount Undisclosed | Is PE deal No |
Target Company Valuation -- | Is deal PE backed Yes |
Techniques Secondary Sale, Management Buy-out (MBO) | Total Acquired 65% |
Investor Sponsors
--
Deal Amount
Undisclosed
Target Company Valuation
NaN
Techniques
Secondary Sale, Management Buy-out (MBO)
Stake Tags
Majority
Is PE deal
No
Is deal PE backed
Yes
Total Acquired
65%
Funding
Keywords
Keywords
Classified
Private
© 2026 PrivCo Holding Inc. All rights reserved.
No AI Training or Automated Data Extraction.
Use of this page or any content or data made available by PrivCo for scraping, crawling, indexing, caching, extracting, copying, reproducing, storing, or for training or developing any artificial intelligence or machine learning system is strictly prohibited without prior written consent. All access to and use of this page and PrivCo's services are subject to the PrivCo Terms of Use: https://www.privco.com/terms-of-use. No license or right is granted by implication or otherwise.